|
|
|
|
| LEADER |
01000cam a2200265 4500 |
| 001 |
663262828 |
| 003 |
DE-627 |
| 005 |
20230905072308.0 |
| 007 |
tu |
| 008 |
110628s2012 xxu||||| 00| ||eng c |
| 010 |
|
|
|a 2011018560
|
| 020 |
|
|
|a 9781613248652
|c hardcover
|9 978-1-61324-865-2
|
| 035 |
|
|
|a (DE-627)663262828
|
| 035 |
|
|
|a (DE-599)GBV663262828
|
| 035 |
|
|
|a (OCoLC)837936216
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 044 |
|
|
|c XD-US
|
| 050 |
|
0 |
|a QP517.B44
|
| 060 |
|
0 |
|a QW 800
|
| 082 |
0 |
|
|a 660.6
|q LOC
|2 23
|
| 084 |
|
|
|a 15,3
|2 ssgn
|
| 084 |
|
|
|a 44.38
|2 bkl
|
| 084 |
|
|
|a 44.09
|2 bkl
|
| 245 |
1 |
0 |
|a Bioactive compounds
|b types, biological activities and health effects
|c Ahmed Bitterlich and Sahar Fischl, eds.
|
| 264 |
|
1 |
|a New York, NY
|b Nova Science Publ.
|c 2012
|
| 300 |
|
|
|a XII, 438 S.
|b Ill., graph. Darst.
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 490 |
0 |
|
|a Biotechnology in agriculture, industry and medicine
|
| 490 |
0 |
|
|a Nova biomedical
|
| 500 |
|
|
|a Includes bibliographical references and index
|
| 505 |
8 |
0 |
|t Calcium orthophosphate bioceramics
|r Sergey V. Dorozhkin
|
| 505 |
8 |
0 |
|t Identification and antioxidants activity of flavonoids from Dhokar and Gemri-Dhokar olive cultivars growing in south of Tunisia
|r Ghayth Rigane, Sami Sayadi, Mohamed Bouaziz
|
| 505 |
8 |
0 |
|t Insight into understanding the molecular mechanism of obesity associated diabetes
|r K. Shilpa, B.S. Lakshmi
|
| 505 |
8 |
0 |
|t Anti-inflammatory action of phloroglucinol derivatives
|r Elena M. Balboa ... [et al.]
|
| 505 |
8 |
0 |
|t Naphthoquinones : biological activities and toxicological effects
|r Brígida R. Pinho ... [et al.]
|
| 505 |
8 |
0 |
|t The role of bioactive compounds in weight management and obesity : health implications
|r R. Campos-Vega, Dave B. Oomah
|
| 505 |
8 |
0 |
|t Potential applications of bacteriocins as bioactive substances for human health
|r Maria Elena Fátima Nader-Macias, Esteban Verta Pingitore, Maria Silvina Juarez Tomas
|
| 505 |
8 |
0 |
|t Alternative approaches for the prevention of bovine mastitis : probiotics, bioactive compounds, and vaccines
|r María Elena Fátima Nader-Macías ... [et al.]
|
| 505 |
8 |
0 |
|t Supercritical fluid extraction of bioactive compounds
|r Lourdes Casas Cardoso ... [et al.]
|
| 505 |
8 |
0 |
|t Pleiotropic effects of red yeast rice (Monascus purpureus)
|r Ying Wei, David G. Popovich
|
| 505 |
8 |
0 |
|t Bioactive compounds from microalgae : interesting case studies from Egypt
|r Nermin Adel El Semary
|
| 505 |
8 |
0 |
|t Marine bacteria as a source of new antibiotics
|r Suelen Egan, Anahit Penesyan
|
| 505 |
8 |
0 |
|t Edible mushrooms : source of bioactive compounds
|r Eva Guillamon
|
| 505 |
8 |
0 |
|t Bioactive compounds
|r J. Meenupriya
|
| 505 |
8 |
0 |
|t Haplophyllum species as a rich source of bioactive natural principles
|r J.M. Prieto-Garcia
|
| 505 |
8 |
0 |
|t Pharmacological potential of the bioactive compounds from Rizoma chuanxiong in the treatment and prevention of the CNS disorders
|r Jianhui Rong
|
| 505 |
8 |
0 |
|t Polyphenolics for osteoarthritis
|r Chwan-Li Shen ... [et al.].
|
| 650 |
|
0 |
|a Biological products
|
| 650 |
|
0 |
|a Biological products
|x Therapeutic use
|
| 650 |
|
2 |
|a Biological Products
|x pharmacology
|
| 650 |
|
2 |
|a Biological Products
|x therapeutic use
|
| 650 |
|
2 |
|a Biological Factors
|x pharmacology
|
| 650 |
|
2 |
|a Biological Factors
|x therapeutic use
|
| 689 |
0 |
0 |
|D s
|0 (DE-588)4371693-3
|0 (DE-627)183787102
|0 (DE-576)211737062
|a Biokeramik
|2 gnd
|
| 689 |
0 |
|
|5 (DE-627)
|
| 700 |
1 |
|
|a Bitterlich, Ahmed
|4 oth
|
| 700 |
1 |
|
|a Fischl, Sahar
|4 oth
|
| 856 |
4 |
2 |
|u http://www.gbv.de/dms/bs/toc/663262828.pdf
|m V:DE-601
|m B:DE-84
|q pdf/application
|v 2012-06-04
|x Verlag
|y Inhaltsverzeichnis
|3 Inhaltsverzeichnis
|
| 912 |
|
|
|a GBV_ILN_20
|
| 912 |
|
|
|a ISIL_DE-84
|
| 912 |
|
|
|a SYSFLAG_1
|
| 912 |
|
|
|a GBV_KXP
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a SSG-OPC-PHA
|
| 912 |
|
|
|a SSG-OPC-DE-84
|
| 912 |
|
|
|a GBV_ILN_70
|
| 912 |
|
|
|a ISIL_DE-89
|
| 936 |
b |
k |
|a 44.38
|j Pharmakologie
|0 (DE-627)106409743
|
| 936 |
b |
k |
|a 44.09
|j Medizintechnik
|0 (DE-627)106421557
|
| 951 |
|
|
|a BO
|
| 953 |
|
|
|2 045F
|a 660.6
|
| 980 |
|
|
|2 20
|1 01
|x 0084
|b 1261618432
|c 00
|f --%%--
|d 2920-4654
|e --%%--
|j --%%--
|y k
|z 03-05-12
|
| 980 |
|
|
|2 70
|1 01
|x 0089
|b 126541291X
|c 00
|f --%%--
|d T 12 B 4052
|e u
|j --%%--
|y z
|z 15-05-12
|
| 984 |
|
|
|2 20
|1 01
|x 0084
|a 84$029204654
|
| 984 |
|
|
|2 70
|1 01
|x 0089
|a 89$134889754
|
